إعلان
إعلان

AIM

AIM logo

AIM ImmunoTech Inc.

1.28
USD
برعاية
-0.06
-4.38%
٠٩ يناير, ١٥:٥٦ UTC -5
مغلق
exchange

بعد الإغلاق

1.31

+0.03
+2.27%

تقارير أرباح AIM

النسبة الإيجابية المفاجئة

AIM تفوق 14 من 29 آخر التقديرات.

48%

التقرير التالي

بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.97
التغير الضمني من Q3 25 (Revenue/ EPS)
-100.00%
/
-38.22%
التغير الضمني من Q4 24 (Revenue/ EPS)
-100.00%
/
-90.30%

AIM ImmunoTech Inc. earnings per share and revenue

On ١٧ نوفمبر ٢٠٢٥, AIM reported earnings of -1.57 USD per share (EPS) for Q3 25, missing the estimate of -0.98 USD, resulting in a -59.42% surprise. Revenue reached 26.00 ألف, compared to an expected --, with a 0.00% difference. The market reacted with a -7.64% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -0.97 USD, with revenue projected to reach -- USD, implying an نقصان of -38.22% EPS, and نقصان of -100.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, AIM ImmunoTech Inc. reported EPS of -$1.57, missing estimates by -59.42%, and revenue of $26.00K, 0% as expectations.
The stock price moved down -7.64%, changed from $1.44 before the earnings release to $1.33 the day after.
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
Based on 3 المحللين, AIM ImmunoTech Inc. is expected to report EPS of -$0.97 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان